Prescription

MRD / Regn No.

: 20260000315

Date

: 22/07/2026

Patient Name

: Punam Saha

Age & Gender

: 36 Yrs. / Female

Contact No.

: 9831731751

UHID

Ht / Wt / BMI

: 161 / 76 / 29.32

BP S / BP D

: /

Allergies

: NKA

Referred By

Problem List	:	TYPE 2 DM (15/Apr/2026) \| OBESITY (15/Apr/2026) \| OBESITY WITH METABOLIC COMPLICATIONS (15/Apr/2026) \| VITAMIN D DEFICIENCY (15/Apr/2026) \|
Subjective	:	HX OF GDM,POST GDM RECURRENCE OF DM,DYSESTHESIAS,HAS STOPPED MEDICATIONS
Objective	:	NONE
Analysis	:	OBESITY,TYPE 2 DM,VITAMIN D DEFICIENCY
Plan	:	INCREASE MOUNJARO 5 MG,SEE ME IN 2 MONTHS WITH TESTING
Salient Investigations	:	TOTAL CHOLESTEROL: 194.97 mg/dl \| FASTING PLASMA GLUCOSE (FPG): 111.72 mg/dL \| POST PRANDIAL GLUCOSE (2HPP): 139.31 mg/dL

S#	Generic (Trade) Name	Route	Dosage	Usage	Duration
1	CAPSULE CHOLECALCIFEROL 2000 IU D RISE Medicine For VITAMIN D	PO	0-0-1	AT BEDTIME	TILL NEXT VISIT

2	INJECTION TIRZEPATIDE 5 MG MOUNJARO Medicine For OBESITY DIABETES	SQ	ONCE A WEEK	AS DIRECTED NO RELATION TO FOOD	TILL NEXT VISIT
	MAY CAUSE NAUSEA VOMITING OR DIARRHEA

Refill : 0 / Substitution:

Education

: RARE VERY RARE INSTANCES OF EYE DISTURBANCE WITH TIRZEPATIDE HAVE BEEN REPORTED

Next Visit

: 21/Aug/2026

Tests Suggested For Next Visit

: FBS 2HPP HBA1C